118
-Munoz N., Bosch F.X., de Sanjose S., Herrero R., Castellsague X., Shah KV., Snijeders P.J., 1
Meijers C.J., Epidemiologic classification of human papillomavirus types associated with 2
cervical cancer. The New England journal of Medicine, 2003; 348: 518-527. 3
4
-Pudney J., Quayle A.J., Anderson D.J., Immunological Microenvironments in Human Vagina 5
and Cervix: Mediators of Cellular Immunity are Concentrated in the Cervical Transformation 6
zone. Biology of Reproduction, 2005; 1253-1263. 7
8
-Reeves JD, Doms RW. Human immunodeficiency virus type 2. J Gen Virol. 2002; 83:1253-9
1265. 10
11
-Rezza G, Giuliani M, Branca M, Benedetto A, Migliore G, Garbuglia AR, D'Ubaldo C, Pezzotti 12
P, Cappiello G, Pomponi Formiconi D, Suligoi B, Schiesari A, Ippolito G, Giacomini G. 13
Determinants of squamous intraepithelial lesions (SIL) on Pap smear: the role of HPV infection 14
and of HIV-1-induced immunosuppression. Eur J Epid. 1997; 13:937-943. 15
Rizzardi GP, Pantaleo G. The immunophatogenesis of HIV-1 infection. In: Polsky BW, Clumeck 16
N. HIV and AIDS. London: Mosby-Wolfe Medical Communications; 1999: 6.1-6.12. 17
18
-Richart R.M., Cervical Intraephitelial Neoplasia. Pathology Annual, 1973; 8:301-328. 19
20
-Robbins S.L., Cotran R.S., Kumar V., Abbas A.K., Fausto N., Patologia – Bases Patológicas das 21
Doenças, 2005,editora Elsevier, 7ª edição, Rio de Janeiro, 1592 páginas. 22
23
-Rowhani-Rahbar A, Hawes SE, Sow PS, Toure P, Feng Q, Dem A, Dembele B, Critchlow CW, 24
N’Doye I, Kiviat NB. The impact of HIV Status and type on the clearance of human 25
papillomavirus infection among Senegalese women. J Inf Dis. 2007; 196:887-894. 26
27
-Schiffman M., Castle P.E., Jeronimo J., Rodriguez A., Wacholder S. Human papillomavirus and 28
cervical cancer. Lancet. 2007; 370:890-907. 29
30
-Schiffman M.H. Recent progress in defining the epidemiology of human papillomavirus 31
infection and cervical neoplasia. Journal of the National Cancer Institute.1992;84:394-398. 32
33
-Smith J.S., Lindsay L., Hoots B. et al. Human papillomavirus type distribution in invasive 34
cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer. 2007; 121: 35
621-632. 36
37
-Sinal S.H. & Woods C.R. Human Papillomavirus infections of the genital and respiratory tracts 38
in young children. Semin Pediatr Infect Dis. 2005; 16:306-316. 39
40
-Sun XW, Kuhn L, Ellerbrock TV, Chaisson MA, Bush TJ, Wright TC. Human papillomavirus 41
infection in women infected with the human immunodeficiency virus. New England Journal of 42
Medicine, 1997; 337:1343. 43
44
-Syrjänen K, Shabalova I, Petrovichev N, Kozachenko V, Zakharova T, Pajanidi J, Podistov J, 45
Chemeris G, Sozaeva L, Lipova E, Tsidaeva I, Ivanchenko O, Pshepurko A, Zakharenko S, 46
Nerovjna R, Kljukina L, Erokhina O, Branovskaja M, Nikitina M, Grunberga V, Grunberg A, 47
Juschenko A, Santopietro R, Cintorino M, Tosi P, Syrjanen S. Oral contraceptives are not an 48